Shire presents new lysosomal disease research at 2018 WORLDSymposium

Shire is attending this year's WORLDSymposium, where it is sharing its latest rare lysosomal disease research insights.

The company is hosting 12 presentations, including 11 posters and one oral presentation, at the conference in San Diego from February 5th to 9th, covering disease areas including Hunter syndrome, type 1 Gaucher disease, Fabry disease and metachromatic leukodystrophy.

During the show, the firm will highlight how lysosomal diseases – a collection of around 50 clinical syndromes resulting from the deficiency of a particular protein – can cause significant amounts of disability, as well as showcasing potential new treatment approaches.

This will underline Shire's ongoing commitment to improving the understanding of rare diseases and creating innovative ways to enhance the early diagnosis and treatment of these conditions.

Dr Hartmann Wellhoefer, vice-president and head of rare diseases and internal medicine at Shire's global medical affairs division, said: "This meeting brings together the world's leading experts in the rare disease community to exchange the latest scientific knowledge and data about lysosomal diseases, along with advocacy groups who share valuable patient insights and perspectives."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.